ADVISORY-Research alert on Nektar Therapeutics refiled to clarify price target
June 25 (Reuters) - A research alert on brokerage H.C. Wainwright raising its price target on Nektar Therapeutics NKTR.O that was published on June 24 has been refiled on June 25 to reflect that the price target is split adjusted.
For the correct alert, click here.
STORY_NUMBER:AZN40ZW4T
STORY_TIME:[041438 GMT]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora

POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now

Palantir Q1 2026 Earnings Preview — Is PLTR a Buy at $144?

Amazon vs. Microsoft: Which Stock Is a Better Buy for 2026 and Beyond?

Tradingkey






